Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.

doi:10.1016/j.humpath.2007.06.012

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.

Human pathology - 1 Feb 2008

Liu Hui, Fan Qinhe, Zhang Zhihong, Li Xiao, Yu Huiping, Meng Fanqing

Abstract excerpt

Previous studies have shown conflicting results on prognostic significance of basal-like breast tumors, but hormone receptor is a confusing factor in most of the prognostic evaluations. We aimed to characterize the prognostic features of basal-like tumors without the influence of hormone receptor status in a series of hormone receptor-negative breast tumors. Using tissue microarray and immunohistochemistry...

Topics

Adenocarcinoma
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Breast Neoplasms
Female
Fluorescent Antibody Technique, Direct
Humans
Kaplan-Meier Estimate
Middle Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Neoplasm Staging

Phenotype

Prognosis

Receptor, ErbB-2

Receptors, Estrogen

Receptors, Progesterone

Survival Rate

Source

Open in PubMed

Identifiers

PMID: 18045647
DOI: 10.1016/j.humpath.2007.06.012

Genes

BRCA1
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.PMID 18045647Read ↗

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.Semantic proximity Read ↗

Basal-like breast carcinoma: a phenotypically distinct entity.Semantic proximity Read ↗

Basal-Like Breast Cancer: A Critical ReviewSemantic proximity Read ↗

[Basal-like breast cancers: clinicopathological features and outcome].Semantic proximity Read ↗

[Basal-like breast cancer: a review].Semantic proximity Read ↗

Biomarkers for Basal-like Breast CancerSemantic proximity Read ↗

Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance.Semantic proximity Read ↗

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.Semantic proximity Read ↗

Prognostic value of basal phenotype in HER2-overexpressing breast cancer.Semantic proximity Read ↗

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes.Semantic proximity Read ↗

Basal phenotype breast cancer: implications for treatment and prognosis.Semantic proximity Read ↗

Clinical and pathologic aspects of basal-like breast cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.